Microneedle-based drug delivery systems for transdermal route

Current Drug Targets

Volumn 15, Issue 3, 2014, Pages 281-291

  Pierre, Maria Bernadete Riemma ^a   Rossetti, Fábia Cristina ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug delivery; Microneedles; Safety; Skin penetration enhancement; Stratum corneum; Transdermal delivery

Indexed keywords

ACICLOVIR; AMINOLEVULINIC ACID; BACTERIAL ANTIGEN; CALCEIN; CARBOXYFLUORESCEIN; CHIMERIVAX; DESMOPRESSIN; DIPHTHERIA VACCINE; DOCETAXEL; DRUG ADJUVANT; INFLUENZA VACCINE; INSULIN; MANNITOL; METAL; NALTREXONE; NICARDIPINE; PLASMID DNA; STAINLESS STEEL; UNCLASSIFIED DRUG;

CLINICAL TRIAL (TOPIC); DEVICE SAFETY; DISSOLVING MICRONEEDLE; DRUG DELIVERY DEVICE; DRUG DELIVERY MICRONEEDLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HOLLOW MICRONEEDLE; HUMAN; NONHUMAN; POLYMERIC BIODEGRADABLE MICRONEEDLE; REVIEW; SKIN PENETRATION; SOLID MICRONEEDLE; STRATUM CORNEUM; TRANSDERMAL DELIVERY;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MICROINJECTIONS; MICROTECHNOLOGY; NEEDLES; PERMEABILITY; SKIN;

EID: 84896722028     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113146660232     Document Type: Review

References (96)

1. McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2000; 2: 289-313.
2. Gerstel MS, Place VA. Drug delivery device, US Patent 3,964,482, June, 22, 1976.
3. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998; 87(8): 922-5.
4. Kaushik S, Hord AH, Denson DD, et al. Lack of Pain Associated with Microfabricated Microneedles. Anesth Analg 2001; 92: 502-4.
5. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56: 581-7.
6. Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003; 55: 315-28.
7. McAllister DV, Cros F, Davis SP, et al. Three-dimensional hollow microneedles and microtube arrays. Transducers 99, Int. Conf. Solid-State Sens. Actuators, 10th, Sendai, pp. 1098-101. Tokyo: IEEE, 1999.
8. McAllister DV, Kaushik S, Patel PN, et al. Solid and hollow microneedles for transdermal drug delivery. Proc Int Symp Control Release Bioact Mater 1999; 26th, Boston, pp. 192-93. Deerfield, IL:Control Release Soc.
9. Lin WQ, Cormier M, Samiee A, et al. Transermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res 2001; 18: 1789-93.
10. Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system J. Control Rel. 2004; 97: 503-11
11. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release 2007; 117: 227-37.
12. Donnelly RF, Morrowa DIJ, McCarron PA, et al. Microneedlemediated intradermal delivery of 5-aminolevulinic acid: Potential for enhanced topical photodynamic therapy. J Control Release 2008; 129: 154-62.
13. Gupta J, Felner EI, Prausnitz MR. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther 2009; 11(6): 329-37.
14. Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? J Control Rel 2010; 148 (3): 266-82.
15. McAllister DV, Wang PM., Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA 2003; 100 (24): 13755-60.
16. Coulman SA, Anstey A, Gateley C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm 2009; 366: 190-200.
17. Qiu Y, Gao Y, Hu K, Li F. Enhancement of skin permeation of docetaxel: A novel approach combining microneedle and elastic liposomes. J Control Rel 2008; 129: 144-50.
18. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation Eur J Pharm Sci 2009; 36: 511-23.
19. Banks SL, Pinninti RR, Gill HS, et al. Flux Across Microneedletreated Skin is Increased by Increasing Charge of Naltrexone and Naltrexol In Vitro Pharm Res 2008; 25(7): 1677-85.
20. Martanto W, Davis SP, Holiday NR, et al. Transdermal Delivery of Insulin Using Microneedles in Vivo. Pharm Res 2004; 21(6): 947-52.
21. Verbaan FJ, Bal SM, van den Berg DJ, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method J Control Rel 2008; 128: 80-8.
22. Ding Z, Verbaan FJ, Bivas-Benita M, et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Rel 2009; 136: 71-8.
23. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-bases drug delivery systems: microfabrication, drug delivery and safety. Drug Deliv 2010; 17(4): 187-207.
24. Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008; 364: 227-36.
25. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and tranderaml drug delivery. J Control Rel 2005; 104: 51-66.
26. Zhou CP, Liu YL, Wang HL, Zhang PX, Zhang JL. Transdermal delivery of insulin using microneedle rollers in vivo Int J Pharm 2010; 392: 127-33.
27. Pearton M, Allender C, Brain K, et al. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm Res 2008; 25(2): 407-16.
28. Oh JH, Park HH, Do KY, et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm 2008; 69: 1040-5.
29. Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008; 105(12): 2058-63.
30. Yan G, Warner KS, Zhang J, Sharma S, Gale BK. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery Int J Pharm 2010; 391: 7-12.
31. Widera G, Johnson J, Kim L, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 2006; 24: 1653-64.
32. Wu Y, Qiu Y, Zhang S, Qin G, Gao Y. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. Biomed Microdevices 2008; 10: 601-10.
33. Bal, SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008; 35: 193-202.
34. Donnelly RF, Singh TRR, Tunney MM, et al. Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro. Pharm Res 2009; 26(11): 2513-22.
35. Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement ans prediction of insertion force and needle fracture force. J Biomech 2004; 37: 1155-63.
36. Chu LY, Prausnitz MR. Separable Arrowhead Microneedles J Control Rel 2011; 149(3): 242-9
37. Ding Z, Van Riet E, Romeijn S, et al. Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment Pharm Res 2009; 26(7): 1635-42.
38. Zhu Q, Zarnitsyn VG, Ye L, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 2009; 106(19): 7968-73.
39. Xie Y, Xu B, Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine: NBM 2005; 1: 184-90
40. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Rel 2010; 142: 187-95.
41. Koutsonanos DG, Martin MP, Zarnitsyn VG, et al. Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays. PLoS ONE 2009; 4(3): e4773.
42. Gardeniers HJGE, Luttge R, Berenschot EJW, et al. Silicon Micromachined Hollow Microneedles for Transdermal Liquid Transport. J. Microelectromech. Syst 2003; 12: 855-62.
43. Wang PM, Cornwell M, Hill J, Prausnitz MR. Precise microjinjection into skin using hollow microneedles. J Invest Dermatol 2006; 126: 1080-7.
44. Mukerjee EV, Collins SD, Isseroff RR, Smith RL Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actua A Physical 2004; 114: 267-75.
45. Dubin C. Penetrating the market with innovative transdermal technology. Drug Delivery Technology 2009; July/august, 9 (7): 44-47. Available online at http://www.drugdeliverytech-online.com/drug delivery/20090708/?pg=46#pg46, accessed 13 May 2011.
46. Nanopass Technology. Available online at: http://www.nano pass.com/ accessed 05 June 2013.
47. Hilt JZ, Peppas NA. Microfabricated drug delivery devices. Int. J. Pharm 2005; 306: 15-23.
48. Roxhed N, Griss P, Stemme G. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Biomed Microdevices 2008; 10: 271-9.
49. Wang PM, Cornwell M, Hill J. and Prausnitz MR. Precise Microinjection into Skin Using Hollow Microneedles. J Invest Dermatol 2006; 126: 1080-87.
50. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 2009; 6: 343-54.
51. Braybrook JH. Biocompatibility. In: Biocompatibility Assessment of Medical Devices and Materials, New York, John Wiley and Sons, 1997, pp. 97-109.
52. Chandrasekaran S, Frazier AB. Characterization of surface micromachined metallic microneedles JMEMS 2003; 12: 289-95.
53. Chandrasekaran S, Brazzle JD, Frazier AB. Surface micromachined metallic microneedles J MEMS 2003; 12: 281-8.
54. Mikszta JA, Haider MI, Pettis RJ. Microneedle for drug and vaccine delivery: when will the dream become a reality?. In: Wille JJ, editor. Skin delivery systems: Transdermals, dermatologicals, and cosmetic actives. 1st edition, Iowa, Blackwell Publishing; 2006.
55. Sivamani RK, Stoeber B, Wu GC., et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration Skin Res. Technol 2005; 11 (2): 152-6.
56. Dean CH, Alarcon JB, Waterston et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccines 2005; 1: 106-11.
57. Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial. J. Infect Dis 2008; 198: 650-8.
58. Hooper JW, Golden JW, Ferro AM, King AD. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007; 25: 1814-23.
59. Gittard SD, Miller PR, Boehm RD, et al. Multiphoton microscopy of transdermal quantum dot delivery using twophoton polymerization-fabricated polymer microneedles. Faraday Discus 2011; 149: 171-85.
60. Park JH, Allen MG, Prausnitz MR. Polymer microneedles for controlled-release drug delivery Pharm Res 2006; 23: 1008-19.
61. Aoyagi S, Hayato I, Yuich I, Mitsuo F, Ogawa H. Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle Sens Actuators A Physical 2007; 139: 293-302.
62. Jeong WL, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29: 2113-24.
63. Perennes F, Marmiroli B, Matteucci M, et al. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol J Micromech Microeng 2006; 16: 473-9.
64. Lippmann JM, Geiger EJ, Pisano AP. Polymer investment molding: Method for fabricating hollow, microscale parts. Sens Actuators: A Physical 2007; 134: 2-10.
65. Han M, Kim DK, Seong HK, et al. Improvement in antigendelivery using fabrication of a grooves-embedded microneedle array. Sens Actuators B 2009; 137: 274-80.
66. Sammoura F, Kang JJ, Heo YM, Tae SJ, Liwei L. Polymeric microneedle fabrication using a microinjection molding technique. Microsyst Technol 2007; 13: 517-22.
67. Moon SJ, Lee SS. J A novel fabrication method of a micro-needle array using inclined deep x-ray exposure Micromech Microeng 2005; 15: 903-11.
68. Han M, Hyun DH, Park HH, et al. A novel fabrication process for out-of-plane microneedle sheets of biocompatible polymer. J Micromech Microeng 2007; 17: 1184-91.
69. Ovsianikov A, Chichkov B, Mente P, et al. Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int J Appl Ceramic Tech 2007; 4: 22-9.
70. Sullivan SP, Murthy N, Prausnitz MR. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater 2008; 20: 933-8.
71. Ambrose CG, Clanto TO. Bioabsorbable implants: review of clinical experience in orthopedic surgery Ann Biomed Eng 2004; 32: 171-7.
72. Chabri F, Bouris K, Jones T, et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery J. Br Dermatol 2004; 150: 869-77.
73. Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E. Biomaterials Science: An Introduction to Materials in Medicine, New York, Academic Press, 1996.
74. Mikolajewska P, Donnelly RF, Garland MJ, et al. Microneedle pretreatment of human skin improves 5-aminolevulininc acid (ALA)-and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharm Res 2010; 27: 2213-20.
75. Miyano T, Tobinaga Y, Takahiro K, et al. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices, 7,185-8, 2005.
76. Li G, Badkarb A, Nemab S, Kolli CS, Bangaa AK. In vitro transdermal delivery of therapeutics antibodies usingmaltose microneedles. Int J Pharm 2009; 368: 109-15.
77. Kolli CS, Banga AK. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 2008; 25: 104-13.
78. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006; 29: 82-88.
79. Ito Y, Murakami A, Maeda T, Sugioka N, Takada K. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. Int J Pharm 2008; 349: 124-9.
80. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29, 2113-24.
81. Fukushima K, Ise A, Morita H. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 2011; 28: 7-21.
82. Vemulapalli V, Yang Y, Friden PM, Banga AK. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate J Pharm Pharmacol 2008; 60: 27-33.
83. Benson HAE, Namjoshi S. Protein and peptides: strategies for delivery to and across the skin. J Pharm Sci 2008; 97 (9): 3591-610.
84. Matriano JA, Cormier M, Johnson J, et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 2002; 19: 63-70.
85. Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system J Control Rel 2004; 97: 503-11.
86. Widera G, Johnson J, Kim L, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system Vaccine 2006; 24: 1653-64.
87. Mikszta JA, Alarcon JB, Brittingham JM, et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery Nat Med 2002; 8: 415-9.
88. Davis SP, MartantoW, Allen MG, Prausnitz MR. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 2005; 52: 909-15.
89. Mikszta JA, Sullivan VJ, Dean C, et al. Protective Immunization against Inhalational Anthrax: A Comparison of Minimally Invasive Delivery Platforms J Infect Dis 2005; 191: 278-88.
90. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines. Clin. Vacc. Immunol 2007; 14: 375-81.
91. Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv. Drug. Deliv. Rev 2012; 6: 1547-68.
92. Kendall MAF, Chong YF, Alexander C. The mechanical properties of the skin epidermis in relation to targeted gene and drug delivery. Biomaterials 2007; 28: 4968-77.
93. Laurent A, Mistretta F, Bottigioli D, et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007; 25: 6423-30.
94. Boonma A, Narayan RJ and Lee Y-S. Analytical Modeling and Evaluation of Microneedles Apparatus with Deformable Soft Tissues for Biomedical Applications. Computer-aide designs and applications 2013; 10(1): 139-157.
95. Yang M, Zahn JD. Microneedle insertion force reduction using vibratory actuation. Biomed Microdevices 2004; 6: 177-82.
96. Gupta J, Park SS, Bondy B, Felner EI, Prausnitz MR. Infusion pressure and pain during microneedle injection into skin of human Subjects. Biomaterials 2011; 32: 6823-6831.